1177 — Sino Biopharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Sino Biopharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16,432	15,794	16,922	14,118	14,597
Net Total Accounts Receivable
Net Total Receivables	4,076	5,537	6,219	6,199	5,263
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22,794	23,503	25,935	23,806	24,685
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,392	8,516	9,251	9,912	10,288
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	47,210	60,543	64,064	63,605	65,408
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,944	15,345	20,151	22,607	19,556
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	30,463	30,252	34,317	33,130	33,447
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	16,747	30,291	29,747	30,474	31,961
Total Liabilities & Shareholders' Equity	47,210	60,543	64,064	63,605	65,408
Total Common Shares Outstanding